A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus (2018)
Attributed to:
MRC North West Hub for Trials Methodology Research
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(18)30264-4
PubMed Identifier: 30507470
Publication URI: http://europepmc.org/abstract/MED/30507470
Type: Journal Article/Review
Parent Publication: The Lancet Gastroenterology & Hepatology
Issue: 12